BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 2642977)

  • 21. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.
    Jenkins JR; Rudge K; Currie GA
    Nature; 1984 Dec 13-19; 312(5995):651-4. PubMed ID: 6095117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
    Schwartz SA; Shuler CF; Freebeck P
    Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
    Yehiely F; Oren M
    Cell Growth Differ; 1992 Nov; 3(11):803-9. PubMed ID: 1467307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts.
    Beachy TM; Cole SL; Cavender JF; Tevethia MJ
    J Virol; 2002 Apr; 76(7):3145-57. PubMed ID: 11884539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
    Parada LF; Land H; Weinberg RA; Wolf D; Rotter V
    Nature; 1984 Dec 13-19; 312(5995):649-51. PubMed ID: 6390217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of protein phosphatases in malignant transformation.
    Nagao M; Sakai R; Kitagawa Y; Ikeda I; Sasaki K; Shima H; Sugimura T
    Princess Takamatsu Symp; 1989; 20():177-84. PubMed ID: 2562181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meth A fibrosarcoma cells express two transforming mutant p53 species.
    Eliyahu D; Goldfinger N; Pinhasi-Kimhi O; Shaulsky G; Skurnik Y; Arai N; Rotter V; Oren M
    Oncogene; 1988 Sep; 3(3):313-21. PubMed ID: 3060794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes.
    Kelekar A; Cole MD
    Mol Cell Biol; 1986 Jan; 6(1):7-14. PubMed ID: 2946931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-ras activation and expression in transformed mouse lung cell lines.
    Pan YH; Nuzum EO; Hanson LA; Beer DG
    Mol Carcinog; 1990; 3(5):279-86. PubMed ID: 2244960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-regulation of metastatic and transforming activity of normal and mutant ras genes.
    Egan SE; Broere JJ; Jarolim L; Wright JA; Greenberg AH
    Int J Cancer; 1989 Mar; 43(3):443-8. PubMed ID: 2784421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.
    Wolf D; Harris N; Rotter V
    Cell; 1984 Aug; 38(1):119-26. PubMed ID: 6088057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the mutant p53 gene in transformation assays.
    Beenken SW; Raycroft L; Lozano G
    J Surg Res; 1992 Apr; 52(4):401-5. PubMed ID: 1593878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.
    Ridley AJ; Paterson HF; Noble M; Land H
    EMBO J; 1988 Jun; 7(6):1635-45. PubMed ID: 3049071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.
    Schütte J; Minna JD; Birrer MJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2257-61. PubMed ID: 2648396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.